In our study, adjunctive phage treatment resulted in a significant reduction of pro-inflammatory cytokines (IL-6, IL-23, TNFα, IL-1α) in BALF, suggesting that this synergistic mechanism may ultimately lead to better outcomes in patients with VAP. The gene discussed is IL6; the disease is ventilator-associated pneumonia.